Correspondence 0001104659-24-107025 from Camp4 Therapeutics Corp (CAMP) (CIK 0001736730) (CAMP)
Camp4 Therapeutics Corp (CAMP) (CIK 0001736730)
Date: Oct. 8, 2024 · CIK: 0001736730 · Accession: 0001104659-24-107025
AI Filing Summary & Sentiment
File numbers found in text: 333-282241
Letter
CAMP4 THERAPEUTICS CORPORATION
One Kendall Square
Building 1400 West, 3rd Floor
Cambridge, Massachusetts 02139
October 8, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Lauren Sprague Hammill, Division of Corporation Finance
Re: CAMP4 Therapeutics Corporation
Registration Statement on Form S-1, as amended (File No. 333-282241)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CAMP4 Therapeutics Corporation, a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 10, 2024, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski or Lisa Folkerth of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski or Lisa Folkerth of Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 or (617) 951-7791 as soon as the registration statement has been declared effective.
[Signature page follows]
Very truly yours,
CAMP4 THERAPEUTICS
CORPORATION
Show Raw Text
CORRESP
1
filename1.htm
CAMP4
THERAPEUTICS CORPORATION
One Kendall Square
Building 1400 West, 3rd Floor
Cambridge, Massachusetts 02139
October 8, 2024
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Lauren Sprague Hammill, Division of Corporation Finance
Re:
CAMP4 Therapeutics Corporation
Registration Statement on Form S-1, as amended (File No. 333-282241)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, CAMP4 Therapeutics Corporation, a Delaware corporation (the “Company”), hereby requests that
the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern
Time on October 10, 2024, or as soon as possible thereafter. The Company hereby authorizes Thomas Danielski or Lisa Folkerth of Ropes &
Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Thomas Danielski or Lisa Folkerth of
Ropes & Gray LLP, counsel to the Company, at (617) 235-4961 or (617) 951-7791 as soon as the registration statement has been
declared effective.
[Signature page follows]
Very truly yours,
CAMP4 THERAPEUTICS
CORPORATION
By:
/s/ Josh Mandel-Brehm
Name:
Josh Mandel-Brehm
Title:
Chief Executive Officer
cc.
Josh Mandel-Brehm (CAMP4 Therapeutics
Corporation)
cc.
Thomas Danielski (Ropes &
Gray LLP)
cc.
Lisa Folkerth (Ropes &
Gray LLP)
cc.
Siavosh Salimi (Paul Hastings LLP)
cc.
William A. Magioncalda (Paul Hastings
LLP)